Acanthamoeba Keratitis: Current Status and Urgent Research Priorities

Author(s): Naveed Ahmed Khan*, Ayaz Anwar, Ruqaiyyah Siddiqui.

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 30 , 2019

Abstract:

Background: First discovered in the early 1970s, Acanthamoeba keratitis has remained a major eye infection and presents a significant threat to the public health, especially in developing countries. The aim is to present a timely review of our current understanding of the advances made in this field in a comprehensible manner and includes novel concepts and provides clear directions for immediate research priorities.

Methods: We undertook a search of bibliographic databases for peer-reviewed research literature and also summarized our published results in this field.

Results: The present review focuses on novel diagnostic and therapeutic strategies in details which can provide access to management and treatment of Acanthamoeba keratitis. This coupled with the recently available genome sequence information together with high throughput genomics technology and innovative approaches should stimulate interest in the rational design of preventative and therapeutic measures. Current treatment of Acanthamoeba keratitis is problematic and often leads to infection recurrence. Better understanding of diagnosis, pathogenesis, pathophysiology and therapeutic regimens, would lead to novel strategies in treatment and prophylaxis.

Keywords: Parasite, cornea, pathogenesis, nanotechnology, inflammation, blindness.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 30
Year: 2019
Page: [5711 - 5726]
Pages: 16
DOI: 10.2174/0929867325666180510125633
Price: $58

Article Metrics

PDF: 21